Articles, App Notes, Case Studies, & White Papers

  1. IRT? RTSM? What's The Difference? 10/4/2024

    What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?

  2. Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch 4/22/2024

    The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

  3. Why Are Sponsor Organizations Using More Than 1 CTMS Solution? 4/7/2022

    Explore evolutions in the eClinical market, CTMS use in the outsourcing community, and the difficulty in keeping up with requirements that sponsor organizations, CROs, and clinical trial sites experience regarding their CTMS solutions.

  4. Reliable Methods For Examining Long-Term Wearables In Gait & Sway 2/21/2023

    Review this evaluation framework for wear duration when confirming if wearable sensor-based methods for capturing gait and balance impairment in the free-living environment are fit for purpose.

  5. Navigating Wearable Integration: Key Operational Considerations 4/5/2024

    Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.

  6. Why Oncology Drug Development Lags In Digital Biomarkers 5/23/2023

    Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.

  7. Building Patient-Focused eCOA Strategies: Insights And Best Practices 8/24/2022

    Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.

  8. Readying Your Clinical Trial For Linkage With Real-World Data 9/20/2022

    Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.

  9. Driving Successful Obesity Drug Development With GLP-1 Agonists 9/18/2024

    GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.

  10. How A Remote ePRO Solution Helped Reduce Patient Burden 9/19/2022

    Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.